. However, no clinical CE assay for Amio and Dese has yet been reported. The main advantages of CE over HPLC are the much lower operating costs, much better mass-sensitive detection limit (usually 1 fmol with detection of ultraviolet absorbance), higher separation efficiency, and simpler operation. Furthermore, because biological fluids, e.g., serum [14] [15] [16] [17] and urine [17] [18] [19] [20] 
. A highly hydrophobic compound (for structure see Fig. 1 ) with a unusual pharmacokinetics of Amio, its administration over prolonged periods, its serious adverse effects, and issues of compliance are factors that make the routine determination of Amio and its metabolite desethylamiodarone (Dese; see Fig. 1 ) in serum useful for optimizing pharmacotherapy with this drug [3] . For that purpose, various methods based on HPLC have been developed [1-3, 5, 7-11] , and a therapeutic range for Amio of 1.5-4 emol/L has been proposed [1, 3] .
Thus far, HPLC is the most frequently used chromatographic technique in clinical settings. Recently, drug monitoring by capillary electrophoresis (CE) in fused-silica capillaries of 25 to 75 m (i.d.) has been developed, applied to several relevant applications, and shown to be an attractive alternative to HPLC [12] [13] [14] . However, no clinical CE assay for Amio and Dese has yet been reported. The main advantages of CE over HPLC are the much lower operating costs, much better mass-sensitive detection limit (usually 1 fmol with detection of ultraviolet absorbance), higher separation efficiency, and simpler operation. Furthermore, because biological fluids, e.g., serum [14] [15] [16] [17] and urine [17] [18] [19] [20] [24] . Based on our previous work in CE [23, 24] , a clinical assay for monitoring Amio and Dese in 20-.tL aliquots of patients' sera has evolved and is described here. The drug concentrations obtained by CE are compared with those determined by HPLC.
Puinciple of Method
In brief, this method is based on Ohm's Law. After replenishing the capillary with running buffer, we hydrodynamically introduce a short zone of low conductivity (a water plug -1 nmi long) at the inlet side before making an electrokinetic sample injection from a sample solution of low conductivity. During electroinjection, the charged solutes migrate rapidly through the water zone. When the charged solutes reach the interface of the water zone and the running buffer, their electromigrational transport is drastically decreased because the electric field within the water plug is much higher than that within the buffer. As a result, many of the charged solute molecules are effectively concentrated before their electrophoretic separation [24] .
Matenals and Methods
Drugs, chemicals, patients' sera, and control samples. Dese, Amio, and the internal standard L8040 (Fig. 1) , all as hydrochlorides, were received from Sanofi (Basel, Switzerland). . New capillaries were conditioned with 1 molIL NaOH for 30 mm, and capillary equilibration between assays was effected by flushing with the following buffer for 3 mm: per liter, 600 mL of 1-propanol and 400 mL of a solution of 37.5 mmolJL Na2HPO4 and 112.5 mmolfL NaH2PO4 (pH 6.35). The inlet buffer vial was filled with this buffer, and the outlet vial was filled with aqueous 3 mmollL Na2HPO4 plus 9 mmoltL NaH2PO4 buffer.
To inject the sample, we applied 10 kV to the capillary for 50 s. During injection, the anode was on the injection side and the current decreased from 5 A to -2 j.s.A.Before electroinjection, a water plug -0.8 mm long was introduced by applying a vacuum of 16.9 kPa for 0.5 s. The run voltage was 25 kV (anode on injection side) and the current was --17 p.A. Solute was detected by on-column measurement of absorbance at 242 nm, the wavelength of peak absorbance for Amio. A PC Integration Pack (version 3.0; Kontron Instruments, Zurich, Switzerland) with a Mandax AT 286 computer system was used for data registration and handling. Quantification was based on five-level internal calibration with peak areas. Typical electropherograms obtained with patients' sera containing low and high concentrations of Amio are depicted in Fig.   2 (B and C). All analytes are completely separated and characterized with high column efficiencies (plate number, -10). Unlike the situation in HPLC, no large peaks for sample solvent were observed.
For comparison, HPLC chromatograms of a blank, a calibrator, and the same two patients' sera are depicted in Fig. 3 . The first three chromatograms were produced the same day, giving a very clean blank (panel A) and well-resolved peaks for Amio, Dese, and L8040 (panels B and C). Fig. 3D , from a different series of chromatograms, shows an interference originating from the extraction process and coeluting with Dese (see below).
For successful operation of this CE process, the solutes must be introduced from a sample matrix of low conductivity (micromolar salt content only [24] ), which requires removal of the salt from serum. Furthermore, because of protein precipitation, proteinaceous samples cannot be directly injected into binary buffers. Thus, one must extract solutes before injection into the capillary. The effect on analytical recovery of the pH of the acetate buffer added for extraction with hexane is shown in Fig.   4 . For all three compounds (Dese, Amio, and L8040), analytical recoveries increased as the pH was increased. This is consistent with the solubility of the analytes in the aqueous phase. At low pH, the hydrophobic solutes are protonated and thus are more soluble in the aqueous phase. The results shown are in good agreement with reports in the literature, in which an extraction pH >6 is recommended [3, 8] . According to Fig. 4 , the recovery of analytes added to serum samples was greatest when no acetate buffer was included, i.e., at serum pH (7.4) [25J. For patients' sera, however, drug concentrations determined without the addition of acetate buffer were considerably smaller than those monitored at pH 6.2. From Fig.  4 , comparison of the data obtained after extraction at serum pH (without acetate buffer, x) with those obtained after extraction at pH 6.2 (y) revealed linear relationships ofy = 1.18x + 0.19 (r = 0.89; n = 6) andy = 2.57x -0.42 (r = 0.81; n = 6) for Dese and Amio, respectively. Thus, acetate buffer appears to be helpful for drug release from serum proteins.
The CE data presented in Fig. 2 and in the rest of this report were obtained after extraction with acetate buffer at pH 6.0.
Using these conditions and various patients' sera, we assessed the effect of the duration of the extraction. The peak-area ratios of Dese and Amio with L8040 were found to be constant for drugs extracted within 20-40 s. Shorter extractions gave insufficient recovery, whereas extracts after prolonged exposures (for >5 mm) of the binary mixture with the polypropylene vial contained additional compounds that produced broad CE peaks. Unfortunately, small glass vials that could be firmly closed for extraction were not available. Thus, we used a 30-s extraction period with vortex-type mixing in a 0.5-mL polypropylene vial, followed by a rapid transfer of the organic phase into a glass tube before evaporation and reconstitution. This procedure could be completed within 2-3 mm and did not reveal any interferences from the plastic vial.
The linearity of the CE response was tested by analyzing blank sera to which five concentrations of Dese (range: 0.30-
mol/L)
and Amio (0.35-8.71 moVL) and 5.43 mol/L L8040 had been added. In 10 calibrations performed on 10 different days with different blank sera, the CVs of the slopes of the calibration lines were 3.8% and 6.4% for Dese and Amio, respectively.
Good correlation coefficients (0.9960-1.0000 and 0.9963-0.9998, respectively) and small intercepts (-0.10 to 0.14 and -0.11 to 0.10 jmol/L, respectively) were observed for the Dese and Amio assays. Although single-concentration calibration can be used, giving r >0.992 and an intercept of less than one-third of the lowest concentration monitored [16] , we calibrated with multiple concentrations to better avoid accidental error.
Analysis of a serum blank supplemented with 0.30 tmol/L Dese and 0.35 Mmol/L Amio gave a lowest detectable concen- Further, only 2 L of the serum sample was actually used in the final preparation of the 100 tL of solution for sample injection.
Given the lack of microliter sample vials and the difficulty in handling microliter volumes of liquids, however, we had to use 20-L aliquots of serum to obtain reproducible results. Thus, the smallest volume of serum needed was not limited by the analytical technique itself but by the tools and vessels for sample transfer and extraction. New technologies will have to be developed to process smaller sample volumes.
The intraday reproducibility was assessed with a patient's serum containing 1.98 tmol/L Dese and 2.43 mol/L Amio. For 10 determinations of this serum, the CVs for Dese and Amio were 6.2% and 3.3%, respectively.
Somewhat lower values are expected for consecutive analyses of control samples. Interday reproducibility was assessed by analyzing commercial control samples on 10 different days. For two drug concentrations, the CVs were <5.2% (Table  1) , similar to the CVs for determinations by HPLC (Table 1 ; [3, 5, . We found that the use of peak-area ratios gave somewhat better reproducibility than did peak-height ratios. Because of the variations in peak size obtained in head-column field-amplified sample stacking Fig. 3D ) were excluded for presentation in Fig. 5  (right) . Differences in the extraction procedures and calibration matrices used for HPLC and CE are unlikely to be responsible for the small deviations observed. However, storage conditions and durations are known to affect determinations of Amio concentrations in serum [10, 11] . After the routine measurement of serum Amio by HPLC, we stored the patients' sera used for drug monitoring in plastic vials at -20 #{176}C for up to several months before analysis by CE. Calibrator solutions were kept at 4 #{176}C in rubber-stoppered glass bottles for no more than 3 months before new solutions were prepared. We did not investigate the stability of the analytes in stored serum and calibrators in this work.
In conclusion, this robust microassay based on liquid/liquid extraction and CE is shown to produce accurate serum concentrations of Amio and Dese that compare well with those obtained by HPLC. Large volumes of patients' sera (0.25-1 mL)
are typically used for monitoring of Amio and Dese by HPLC [1-3, 5, 7-9] . The same is true for previously published CE drug assays in which analytes were extracted before analysis [12, 27] . Because of the high-concentration sensitivity associated with the head-column field-amplified sample-stacking technique used here, however, very little serum (microliter amounts) is required. Furthermore, the CE microassay consumes only small amounts of organic solvents (-1 % of that required for HPLC) and uses inexpensive capillary columns (costs of -2% of that for columns used in HPLC).
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